The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
Uncategorized
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
09 mins
When investors are in a risk-on mood, they often gravitate to growth-oriented technology stocks. When investors are in a risk-off mood, however, they often rotate out of tech and into other areas. High-yielding dividend growth stocks is one area that often sees increased interest when fear is on the rise.
Three dividend growth stocks you’ll want to look at if you are considering shifting out of tech are AbbVie(NYSE: ABBV), Procter & Gamble(NYSE: PG), and Enterprise Products Partners(NYSE: EPD). Here’s why each one is worth buying and holding for the long-term.
Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
AbbVie is a Dividend King drug maker
Pharmaceutical giant AbbVie was spun off from Abbott(NYSE: ABT) and, for tracking purposes, retains Abbott’s dividend record. Because AbbVie has continued to increase its dividend since its spin-off, it is a Dividend King. That means it has over five decades worth of annual dividend increases, making it a highly reliable dividend payer.
AbbVie also has an attractive 3.2% dividend yield. For reference, the S&P 500(SNPINDEX: ^GSPC) is yielding around 1.1%, and the average pharma stock yields 0.7%. While investors have been concerned about generic competition for AbbVie’s Humira, new immunology drugs Skyrizi and Rinvoq appear to be even more effective. That bodes well for the future and doesn’t even account for the company’s strong positions in oncology, neuroscience, and aesthetics.
With an attractive yield, a great dividend history, and a still-strong position in the drug sector, AbbVie could be a good option for investors exiting technology stocks. A $10,000 investment will let you buy around 45 shares of the stock.
Procter & Gamble is a Dividend King consumer staples stock
Another Dividend King to look at today is Procter & Gamble, one of the world’s largest consumer staples companies. Consumers will continue buying the toilet paper, deodorant, and dish soap that P&G sells regardless of the stock market environment or economic conditions. Its products are viewed as necessities, and the company’s focus on innovation and product superiority tends to keep consumers loyal to P&G’s brands.
That said, P&G’s industry-leading position often affords it a premium on Wall Street. However, a recent drawdown has pushed the company’s price-to-sales, price-to-earnings, and price-to-book ratios below their five-year averages. That suggests that this industry-leading business is attractively priced right now. Notably, the 3% dividend yield is well above the industry average of 2%. A $10,000 investment will allow you to buy around 70 shares of P&G.
Enterprise isn’t a Dividend King, but it’s working on it
Enterprise has “only” increased its distribution annually for 27 consecutive years, falling well short of the 50 needed to be a Dividend King. But don’t count this reliable income stock out, since its 27-year streak means this energy business has basically increased its distribution every year since its initial public offering.
While the energy sector can be volatile, Enterprise is really just a boring toll-taker. It charges fees for the use of its massive portfolio of North American energy infrastructure assets, such as pipelines. The volume of energy moving through its system is more important than the price of that energy. Given the importance of oil and natural gas to the global economy, demand for Enterprise’s services tends to remain strong throughout the energy cycle.
However, the big draw with Enterprise will likely be its ultra-high 5.5% distribution yield. The master limited partnership (MLP) has an investment-grade credit rating and covers its distribution with distributable cash flow by 1.7x, so there’s little risk of a cut. Continued slow-and-steady distribution growth is far more likely. A $10,000 investment will get you 250 units.
If tech stocks have you worried, lean into boring dividends
When investors look to reduce risk, they often shift into dividend stocks. But don’t just choose any dividend stock. Pick ones with strong businesses and long histories of rewarding investors with growing income streams. That’s exactly what you’ll get with AbbVie, P&G, and Enterprise, making them attractive options if you are rotating out of tech stocks.
Should you buy stock in AbbVie right now?
Before you buy stock in AbbVie, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $481,589!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,345,714!*
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 208% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Reuben Gregg Brewer has positions in Procter & Gamble. The Motley Fool has positions in and recommends AbbVie and Abbott Laboratories. The Motley Fool recommends Enterprise Products Partners. The Motley Fool has a disclosure policy.
